74 filings
10-Q
2024 Q1
GLTO
Galecto Inc
Quarterly report
29 Apr 24
4:00pm
DEF 14A
GLTO
Galecto Inc
Definitive proxy
29 Apr 24
4:00pm
PRE 14A
GLTO
Galecto Inc
16 Apr 24
Preliminary proxy
4:00pm
8-K
GLTO
Galecto Inc
26 Mar 24
Other Events
4:00pm
S-8
GLTO
Galecto Inc
8 Mar 24
Registration of securities for employees
4:29pm
8-K
0k6 awi2gzjq6
21 Dec 23
Other Events
4:30pm
8-K
mz8fk9nexdlla
23 Oct 23
Galecto Presents Updated Clinical Data at ESMO Congress 2023 and Provides Update on Phase 1b/2a GALLANT-1 Trial
9:00am
8-K
bm0e2gf4050fbq1v
2 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:00pm
8-K
8pcwttlo5m sjx
26 Sep 23
Galecto Announces Plans to Explore Strategic Alternatives
4:05pm
8-K
olt1 zwxba
15 Aug 23
Galecto Announces Topline Results from Phase 2b GALACTIC-1 Trial of GB0139 for the Treatment of Idiopathic Pulmonary Fibrosis
8:00am
8-K
sq1a 757fm5q1
15 Jun 23
Submission of Matters to a Vote of Security Holders
4:00pm
ARS
wxcewo3r3l 5n
28 Apr 23
Annual report to shareholders
9:01am
DEFA14A
i3ulizuvac014unmco
28 Apr 23
Additional proxy soliciting materials
7:45am
8-K
zf6h0cj
10 Mar 23
Regulation FD Disclosure
3:07pm
S-8
3ja 7a5ihdp
9 Mar 23
Registration of securities for employees
6:36am